Bios Partners — 2025 Investments
1 investments dated 2025 · listed companies and verified rows first · show all
Trefoil Therapeuticstrefoiltherapeutics.cominApr 2025✓ verified
Trefoil Therapeutics develops ophthalmologic drugs, with a team focused on drug development and commercialization in the eye-care field.
BiotechHealthtechSan Diego, US
Ralph Bradshaw(Director)Schalon Newton(Executive Officer)David Eveleth(Executive Officer, Director)
BoardChristy Shaffer(Director)
Board seatStella Robertson· per SEC Form D
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.